Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Merck
MRK
|
$446M |
| 2 |
NVIDIA
NVDA
|
$375M |
| 3 |
Apple
AAPL
|
$319M |
| 4 |
EXE
Expand Energy Corporation Common Stock
EXE
|
$317M |
| 5 |
Meta Platforms (Facebook)
META
|
$310M |
Top Sells
| 1 |
SWN
Southwestern Energy Company
SWN
|
$381M |
| 2 |
Exxon Mobil
XOM
|
$324M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
$223M |
| 4 |
SoFi Technologies
SOFI
|
$160M |
| 5 |
VSTO
Vista Outdoor Inc.
VSTO
|
$136M |
Sector Composition
| 1 | Technology | 20.48% |
| 2 | Financials | 18.31% |
| 3 | Industrials | 12.31% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDNW
3226
RideNow Group, Inc. Class B Common Stock
RDNW
$150M
| $117K | ﹤0.01% |
21,621
+9,088
| +73% | +$49.3K |
|
3227
INmune Bio
INMB
$51.8M
| $117K | ﹤0.01% |
25,139
+10,491
| +72% | +$49K |
|
3228
Lantern Pharma
LTRN
$46.5M
| $117K | ﹤0.01% |
36,549
-999
| -3% | -$3.19K |
|
3229
Sagimet Biosciences
SGMT
$231M
| $114K | ﹤0.01% |
+25,334
| New | +$114K |
|
|
IGMS
3230
DELISTED
IGM Biosciences
IGMS
| $114K | ﹤0.01% |
18,604
| – | – |
|
|
WHWK
3231
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.8M
| $112K | ﹤0.01% |
35,595
| – | – |
|
3232
Protara Therapeutics
TARA
$122M
| $111K | ﹤0.01% |
+20,997
| New | +$111K |
|
3233
Coffee Holding Co
JVA
$23.7M
| $110K | ﹤0.01% |
32,263
+19,518
| +153% | +$66.8K |
|
|
SGMA
3234
DELISTED
Sigmatron International
SGMA
| $109K | ﹤0.01% |
61,263
-2,266
| -4% | -$4.03K |
|
|
ALLK
3235
DELISTED
Allakos
ALLK
| $109K | ﹤0.01% |
89,998
| – | – |
|
3236
Medallion Financial
MFIN
$249M
| $108K | ﹤0.01% |
11,451
| – | – |
|
3237
DiaMedica Therapeutics
DMAC
$317M
| $105K | ﹤0.01% |
19,339
+2,380
| +14% | +$12.9K |
|
3238
Optex Systems
OPXS
$80M
| $104K | ﹤0.01% |
15,168
+711
| +5% | +$4.88K |
|
3239
Solid Power
SLDP
$760M
| $104K | ﹤0.01% |
54,878
| – | – |
|
3240
TOP Ships
TOPS
$25.1M
| $101K | ﹤0.01% |
16,669
| – | – |
|
3241
Willamette Valley Vineyards
WVVI
$24.3M
| $100K | ﹤0.01% |
29,941
| – | – |
|
3242
Lipocine
LPCN
$15.7M
| $100K | ﹤0.01% |
20,516
+2,500
| +14% | +$12.2K |
|
3243
Alpha Teknova
TKNO
$233M
| $98.7K | ﹤0.01% |
11,687
-6,168
| -35% | -$52.1K |
|
|
IMMP
3244
Immutep
IMMP
$242M
| $98.7K | ﹤0.01% |
45,489
-2,451
| -5% | -$5.32K |
|
|
HOOK
3245
DELISTED
HOOKIPA Pharma
HOOK
| $97.8K | ﹤0.01% |
48,635
| – | – |
|
3246
Eledon Pharmaceuticals
ELDN
$162M
| $94.9K | ﹤0.01% |
23,033
-11,190
| -33% | -$46.1K |
|
3247
Zura Bio
ZURA
$143M
| $93.2K | ﹤0.01% |
+37,290
| New | +$93.2K |
|
3248
Milestone Pharmaceuticals
MIST
$153M
| $92.9K | ﹤0.01% |
39,450
| – | – |
|
3249
One Stop Systems
OSS
$126M
| $91.6K | ﹤0.01% |
27,355
+5,098
| +23% | +$17.1K |
|
|
BLUE
3250
DELISTED
bluebird bio
BLUE
| $91K | ﹤0.01% |
10,906
-19,288
| -64% | -$161K |
|